Top Tip: Regulations in terms of paragraph (e) of definition of “research and development” in section 11D(1) on criteria for clinical trials in respect or deduction for research and development. Read more here.
The main aim of this incentive is to encourage South African companies to invest in scientific or technological research and development.
The section 11D Research and Development Incentive (R&D) was introduced into the Income Tax Act, in 2006 to replace the previous research and development rule that existed in terms of section 11B.
Section 11D allows:
The R&D adjudication committee is made up of–
The role of the R&D Adjudication Committee includes:
SARS will allow a deduction when:
Top Tip: Even if the taxpayer has received pre-approval of an R&D project, SARS will still retain its audit oversight role.
SARS will work out whether the claimed expenditure is within the boundaries of the expenditure approved by the pre-approval committee. The expenditure is actually incurred in the production of income and in the carrying on of trade.
For more information on the R&D incentive, see the Department of Science & Technology.
To access this page in different languages click on the links below:
Disclaimer
All information, content and data on SARS websites and associated facilities, including but not limited to software, hyperlinks and databases, is the property of or licensed to SARS and is protected under applicable South African laws. Unauthorised usage of content and/or information is strictly prohibited. No person, business or web site may reproduce this site, contents, information or any portion thereof.